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Background: Sesquiterpenes are a class of natural products with a diverse range of attractive industrial
proprieties. Due to economic difficulties of sesquiterpene production via extraction from plants or chemical
synthesis there is interest in developing alternative and cost efficient bioprocesses. The hydrocarbon α-santalene is a
precursor of sesquiterpenes with relevant commercial applications. Here, we construct an efficient Saccharomyces
cerevisiae cell factory for α-santalene production.
Results: A multistep metabolic engineering strategy targeted to increase precursor and cofactor supply was employed
to manipulate the yeast metabolic network in order to redirect carbon toward the desired product. To do so, genetic
modifications were introduced acting to optimize the farnesyl diphosphate branch point, modulate the mevalonate
pathway, modify the ammonium assimilation pathway and enhance the activity of a transcriptional activator. The
approach employed resulted in an overall α-santalene yield of a 0.0052 Cmmol (Cmmol glucose)-1 corresponding to a
4-fold improvement over the reference strain. This strategy, combined with a specifically developed continuous
fermentation process, led to a final α-santalene productivity of 0.036 Cmmol (g biomass)-1 h-1.
Conclusions: The results reported in this work illustrate how the combination of a metabolic engineering strategy with
fermentation technology optimization can be used to obtain significant amounts of the high-value sesquiterpene α-
santalene. This represents a starting point toward the construction of a yeast “sesquiterpene factory” and for the
development of an economically viable bio-based process that has the potential to replace the current production
methods.
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Isoprenoids are a class of natural compounds with
many potential commercial applications (e.g. flavor-
ing agents, fragrances, food colorants, pharmaceut-
ical agents and biofuel precursors), and there has
recently been much interest in biotechnological pro-
duction of these compounds [1-4]. Limitations in
raw material accessibility, low yields and high costs
of the current isoprenoid production through plant
extraction or difficulties with chemical synthesis have* Correspondence: nielsenj@chalmers.se
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reproduction in any medium, provided the orcaused interest in engineering cell factories that can
be used to produce isoprenoids in cost competitive
bioprocesses [5-7]. Isoprenoids are natively produced
in yeast though the mevalonate (MVA) pathway in
which the universal isoprene functional unit isopen-
tenyl diphosphate (IPP) is produced from acetyl-CoA
(Figure 1) [8]. The terminal product IPP and its
isomer dimethylallyl diphosphate (DMAPP) are sub-
sequently condensed in the prenyl diphosphate path-
way generating isoprene derivatives of different chain
length (C5-C20) [9]. The sesquiterpene hydrocarbon
α-santalene is a precursor of commercially relevant
sesquiterpenes (C15) and it is generated in a one-
step conversion from the intermediate building block
farnesyl diphosphate (FPP) [10]. Stoichiometry of
α-santalene (C15H24) production in S. cerevisiae viaal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Genetic engineering approach for increasing α-santalene production. (A) Expression plasmid pISP15 containing tHMG1 encoding
truncated HMG-CoA reductase, a codon optimized santalene synthase gene (SanSynopt) PTEF1 and PPGK1 promoters as well as TADH1 and TCYC1
terminator sequences. (B) Integrated cassettes, rectangles containing arrows represent the promoters and their directionality, pentagons the
genes and empty squares the terminators. (C) Scheme of the engineered mevalonate, prenyl phosphate and ammonium assimilation pathways
and FPP branch point; overexpressed and deleted genes are highlighted. Pathway intermediates: G6P: glucose-6-phosphate, Acetyl-CoAcyt:
cytosolic acetyl-CoA, HMG-CoA: 3-hydroxy-3-methylglutaryl-CoA, MVA: mevalonate, MVA-P: phosphomevalonate, MVA-PP: diphosphomevalonate,
IPP: isopentenyl diphosphate, DMAPP: dimethylallyl diphosphate, GPP: geranyl diphosphate, FPP: farnesyl diphosphate, FOH: farnesol.
Overexpressed genes are tHMG1 (encoding truncated HMG-CoA reductase), ERG20 (encoding FPP synthase), GDH2 (encoding NAD-dependent
glutamate dehydrogenase), and SanSynopt (encoding α-santalene synthase). Deleted genes are GDH1 (encoding NADP-dependent glutamate
dehydrogenase), LPP1 and DPP1 (both encoding lipid phosphate phosphatases). The promoter of the ERG9 gene (encoding squalene synthase) is
replaced with PHXT1. Genes whose promoters contain Upc2 binding sites are indicated with a grey arrow: ERG13 (encoding HMG-CoA synthase),
ERG12 (encoding mevalonate kinase), and ERG8 (encoding phosphomevalonate kinase). Additional genes indicated are ERG10 (encoding
acetoacetyl-CoA thiolase), ERG19 (encoding diphosphomevalonate decarboxylase) and IDI (encoding IPP isomerase).
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tions can be summarized as:
4:5 C6H12O6  9 ATP 6 NADPHþ C15H24 þ
18 NADHþ 12 CO2 ¼ 0
which demonstrates that α-santalene production involves
a net consumption of ATP and NADPH, whereas there is
a net production of NADH.
Considerable efforts have been made to engineer
yeast for isoprenoid production [8,11]. Recently, pro-
gress has been reported in developing a S. cerevisiae
strain capable to produce commercially relevant
amounts of α-santalene [12], and the aim of the
present work was to develop a S. cerevisiae produc-
tion platform for sesquiterpene compounds that
could serve as an inexpensive, environmentally com-
patible alternative to current production methods.
We undertook a multistep metabolic engineering
strategy combining four different approaches to increase
α-santalene production. These included: (i) Modulation
and optimization of the FPP branch point (ii) Modulation
of the MVA pathway to increase the precursor pool
for isoprenoid synthesis (iii) Increasing the availability
of the reductive cofactor NADPH by modifying the
ammonium assimilation pathway and (iv) Enhancing
the activity of a transcriptional activator of sterol
biosynthesis.
(i) In order to minimize the overflow to the biosynthe-
tically related sterols that have the same precursor as
α-santalene, FPP, the native promoter (PERG9) of squa-
lene synthase (SQS) was replaced with a glucose sensing
PHXT1 promoter [12]. Previous attempts to increase
cytosolic FPP availability by down-regulating the ERG9
gene resulted in a rapid dephosphorylation of FPP to
farnesol (FOH) [13-15]. To minimize the flux towards
farnesol two genes, LPP1 and DPP1, encoding enzymes
with FPP dephosphorylation activity have been deleted
[12,16], and we also adapted this approach here
(Figure 1).
(ii) As a second part of the strategy we amplified the
flux through the MVA pathway by engineering two key
enzymatic steps. The mevalonate producing 3-hydroxy-
3-methyl-glutaryl-CoA reductase (HMGR) enzyme is a
highly regulated enzyme and is generally believed to
exert a high degree of flux control in the MVA pathway.
Part of its regulation is via the N-terminal domain of
Hmg1 that spans the membrane of the endoplasmic
reticulum (ER) and hereby interacts with sterol sensing
components of the ER membrane. This feed-back regu-
lation by sterols can be eliminated by expressing a modi-
fied form of HMGR lacking the trans-membrane region
[17]. Here we used a genetic modification widely used in
the past in order to circumvent post-transcriptionalregulation of HMGR [18]. The HMG1 gene region cod-
ing for the catalytic domain was over-expressed resulting
in a constitutively active, cytosolic variant of Hmg1. This
strategy has been successfully used before for over-
producing several different isoprenoids in S. cerevisiae
[12,14,19-21]. The other enzymatic step engineered in
the MVA pathway was the one mediated by farnesyl di-
phosphate synthase (FPPS) (encoded by the essential
gene ERG20), which catalyses the condensation of IPP
units into geranyl diphosphate (GPP) and FPP [22]. IPP
condensing enzymes are interspecies conserved and the
yeast ERG20 gene product evolved towards specific pro-
duction of FPP rather than GPP [23]. Due to the pivotal
nature of the FPP molecule as precursor of many essen-
tial compounds such as dolichol, ubiquinone, isopreny-
lated proteins and ergosterol [24] its synthesis by FPPS
is tightly regulated and has been identified as a flux con-
trolling step of the MVA pathway, in particular control-
ling the intracellular FPP availability and its distribution
into derived products [25,26]. The efficiency of ERG20
overexpression to increase the level of IPP conversion to
FPP and its derivatives depends, however, on the growth
conditions employed and the yeast background strain
utilized [20,27]. In this study, the effect of overexpres-
sing ERG20 on α-santalene production has been
investigated.
(iii) The manipulation of the NADH and NADPH co-
factor balance in order to overcome limits imposed from
the cellular redox constraints is a well-established meta-
bolic engineering strategy [28]. The reaction leading to
α-santalene formation results in net production of
NADH and consumption of NADPH (see reaction
above). A change in the NADH:NADPH ratio in favor of
NADPH would therefore be beneficial for product for-
mation. Increasing the availability of reduced cofactor
NADPH by deleting the NADPH consuming reaction of
glutamate dehydrogenase encoded by GDH1 has
previously been applied to improve product formation
[29]. Similarly, activation of an alternative ammonium
utilization route in a gdh1Δ strain by overexpressing the
NAD-dependent glutamate dehydrogenase encoded by
GDH2 resulted in an increase of NADH consumption
during the anabolic process and in a modification of the
yeast cofactor balance [30]. More recently, in silico ana-
lysis identified the same strategy as an approach to
increase sesquiterpene production [31]. Here we evalu-
ated the effect of GDH1 deletion alone as well as
coupled with simultaneous over-expression of GDH2 on
α-santalene production (Figure 1).
(iv). The last strategy we employed involved engineer-
ing of a key transcription factor with the objective to
generally up-regulate expression of the MVA pathway
genes. Upc2 and Ecm22 have been identified as the main
transcription factors responsible for the activation of
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point mutation upc2-1 discovered first for conferring the
ability to assimilate extracellular sterols during aerobic
cultivation [33] has been demonstrated to result in a
constitutively active form of Upc2 [34]. Overexpression
of upc2-1 has been employed to transcriptionally up-
regulate the MVA pathway genes during isoprenoid pro-
duction, but its effect on enhancing the carbon flow
through the pathway was modest when used alone
[19,20]. However, when combined together with ERG9
down-regulation, it produced a clear increase in total
isoprenoid production [20,35]. In the current work, con-
tribution of the upc2-1 overexpression on the produc-
tion of α-santalene was tested in combination with the
modifications described above.
Although these strategies have been employed before
for increasing sesquiterpene production in yeast, they
are here for the first time combined in a single strain.
All the genetic modifications described above were inte-
grated into the yeast genome to enhance the genetic
stability of the production strain during long term culti-
vation. However, in order to ensure flexibility and to
allow the platform strain to be used for production of a
range of different isoprenoids, we expressed the synthase
gene required for the final conversion of FPP into
α-santalene together with an additional copy of tHMG1
on a multicopy plasmid (Figure 1). The effect of the dif-
ferent metabolic engineering strategies on isoprenoid
production was evaluated using an integrated fermenta-
tion/downstream recovery process with a two-phase par-
titioning continuous cultivation set-up (Figure 2). By
combining the different strategies we developed a yeast
strain and a fermentation process that resulted in high
sesquiterpene titers and the results represent a first step
toward the long term goal of establishing an efficient
sesquiterpene production process.
Results
The primary objective of this study was to enhance the
availability of intracellular FPP to increase the production
level of the sesquiterpene α-santalene and to evaluate the
metabolic response of S. cerevisiae to the genetic modifi-
cations. A double phase continuous cultivation method
was developed as production process to investigate the
performances of the engineered strains at glucose-limited
conditions.
Characterization of engineered sesquiterpene producing
strains in two-phase chemostat cultivation
S. cerevisiae was engineered to produce α-santalene
by introducing the expression plasmid pISP15 con-
taining a copy of tHMG1 and codon optimized San-
Syn (SanSynopt) under control of the PGK1 and
TEF1 promoters, respectively (strain SCIGS28). Thetransformed strain was initially tested for its α-
santalene producing capacity in a double-phase
chemostat process at a dilution rate of 0.05 h-1
resulting in an α-santalene yield of 0.0013 Cmmol
(Cmmol glucose)-1 and a production rate of 0.006
Cmmol (g biomass)-1 h-1 (corresponding to 0.086 mg
(g biomass)-1 h-1). All the following strain develop-
ment strategies were assessed based on the yield and
productivity of this control strain (SCIGS28) and are
reported in Figures 3 and 4, whereas the titers are
given in Figure 5.
Replacement of the native PERG9 promoter with PHXT1
was previously proven to efficiently reduce ergosterol
production and increase the availability of FPP for the
conversion into sesquiterpene products [12]. Here, the
same modification was introduced in an lpp1Δ strain
carrying the expression vector resulting in strain
SCIGS29. Using PHXT1 to control ERG9 expression com-
bined with LPP1 deletion resulted in an increase in
α-santalene yield and productivity of 3- and 3.8-fold, re-
spectively. α-Santalene production was accompanied by
the formation of the FPP-derived farnesol (FOH) at a
production rate of 0.006 Cmmol (g biomass)-1 h-1
(Figure 3A). The impact of the additional deletion of
DPP1 was tested in an attempt to reduce the rate of hy-
drolysis of FPP into the undesired by-product FOH
(strain SCIGS30). This resulted in an almost unchanged
flux towards α-santalene formation, but in a reduction
of the farnesol yield and productivity by 50% and 44%,
respectively.
In a following approach, the impact of perturbing the
redox metabolism on α-santalene accumulation was
evaluated introducing the deletion of GDH1 encoding
NADP-dependent glutamate dehydrogenase (strain
SCIGS31). In the strain harboring the additional GDH1
deletion, no further enhancement in α-santalene prod-
uctivity was detected. Interestingly, no substantial FOH
formation was detected in this strain (Figure 3A and 4).
Subsequently, we monitored the effect of activating an
NADH consuming reaction for ammonium assimilation
together with the up-regulation of the second MVA
pathway flux controlling step FPPS, integrating and
over-expressing simultaneously the genes GDH2 and
ERG20 (strain SCIGS24). This combination resulted in a
significant increase of sesquiterpene production contrib-
uting to attain the maximum α-santalene yield and prod-
uctivity of 0.0052 Cmmol (Cmmol glucose)-1 and 0.036
Cmmol (g biomass)-1 h-1, respectively. The additional
up-regulation of GDH2 and ERG20 combined with all
previous features produced a 4- and 6-fold improve-
ment, respectively, in α-santalene yield and productivity
compared to the control strain (Figure 3A and 4).
The MVA pathway was further engineered by integrat-
ing into the yeast genome the mutated transcription
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Figure 2 Set-up of the in situ product removal (ISPR) chemostat cultivation process. A stirred tank reactor is operated in continuous
cultivation mode as double phase system feeding culture medium (light grey) and organic solvent (dark grey). The product is continuously
captured in the organic phase due to its high hydrophobicity. In an integrated downstream step the two phases of the effluent are partitioned in
a settler. Subsequently, the product is recovered from the organic phase, which can then be further recycled in the same process. The exhausted
medium is discarded.
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SCIGS25). Previously, both strategies, using an add-
itional genome integrated copy of tHMG1 next to
plasmid-based expression and the over-expression of
upc2-1 have displayed little or only a strain-dependent
effect on final product production [14,20]. Similarly, our
combined approach did not contribute to increase
α-santalene production over the best producing strain
obtained, SCIGS24. However, in contrast to the insignifi-
cant change in α-santalene productivity strain SCIGS25
exhibited a 2-fold increase in FOH formation yielding a
final FOH yield of 0.0024 Cmmol (Cmmol glucose)-1
and a productivity of 0.018 Cmmol (g biomass)-1 h-1. It
is therefore worth mentioning that strain SCIGS25
reached the highest total sesquiterpene yield and prod-
uctivity of 0.0069 Cmmol (Cmmol glucose)-1 and 0.052
Cmmol (g biomass)-1 h-1 (santalene + farnesol), respect-
ively (Figure 3A and 4).
Evaluation of sesquiterpene production strains at
different dilution rates
Under the employed conditions, the engineered strains
exhibited significant changes in the total amount of sesqui-
terpene produced. The sesquiterpene productivity level var-
ied almost 10-fold between the strains, from 0.006 to 0.052Cmmol (g biomass)-1 h-1. Chemostat cultivation mode
offers the advantage of manipulating with accuracy the di-
lution rate, which at these conditions is equal to the specific
growth rate [36]. We therefore decided to investigate the
behavior of the sesquiterpene production strains at two dif-
ferent growth rates. All previous cultivations were per-
formed at a dilution rate of 0.05 h-1 and when the control
strain was grown at D = 0.1 h-1, a small decrease in the
α-santalene yield was observed (Figure 4) whereas its prod-
uctivity remained essentially unchanged (Figure 3). The in-
crease in α-santalene production observed for strains
SCIGS29 and SCIGS30 at low dilution rate (D = 0.05 h-1)
was also seen at the higher dilution rate of 0.1 h-1.
α-Santalene productivities measured for these strains were,
respectively, 0.041 and 0.043 Cmmol (g biomass)-1 h-1
representing a 6-fold increase compared to the control
strain and almost a 2-fold increase compared to the prod-
uctivity at D = 0.05 h-1 (Figure 3B). In contrast, the yield
was slightly reduced. Consistently, the DPP1 deletion
resulted in reduced FOH accumulation in strain SCIGS30
compared to the lpp1Δ single deletion (strain SCIGS29).
The ratios between the α-santalene and the farnesol yield
in the two strains of 2.3 and 4.2, respectively, were main-
tained when the dilution rate was raised to 0.1 h-1 (Figure 4).
Consistently, the same product proportion was also seen in
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Figure 3 Sesquiterpene productivity in a two-phase partitioned glucose-limited aerobic chemostat. α-Santalene and farnesol production
rate in Cmmol (g biomass)-1 h-1 (the C-molar weight of α-santalene and farnesol are, respectively, 13.62 and 14.82 g Cmol-1). (A) Strains SCIGS28
(tHMG1"), SCIGS29 (+ PHXT1-ERG9, lpp1Δ), SCIGS30 (+ dpp1Δ), SCIGS31 (+ gdh1Δ), SCIGS24 (+ ERG20", GDH2"), SCIGS25 (+ upc2-1", tHMG1")
cultivated at dilution rate D = 0.05 h-1. (B) Strains SCIGS28 (tHMG1"), SCIGS29 (+ PHXT1-ERG9; lpp1Δ), SCIGS30 (+lpp1Δ) cultivated at dilution rate
D = 0.1 h-1. Error bars represent the standard deviation from three independent cultivations.
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Figure 4 Sesquiterpene yield in a two-phase partitioned glucose limited aerobic chemostat. α-Santalene and farnesol yield in Cmmol
(Cmmol glucose)-1. Strains SCIGS28 (tHMG1"), SCIGS29 (+ PHXT1-ERG9, lpp1Δ), SCIGS30 (+ dpp1Δ) were cultivated at dilution rate D = 0.05 h-1 and
D = 0.1 h-1. Strains SCIGS31 (+ gdh1Δ), SCIGS24 (+ERG20", GDH2"), SCIGS25 (+ upc2-1", tHMG1") were cultivated at dilution rate D = 0.05 h-1.
Error bars represent the standard deviation from three independent cultivations.
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Figure 5 α-Santalene titers in a two-phase partitioned glucose limited aerobic chemostat. α-Santalene (bottom) and farnesol (top) titers
expressed in mg l-1 and Cmmol l-1 (the C-molar weight of α-santalene and farnesol are respectively 13.62 and 14.82 g Cmol-1). Strains SCIGS28
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(+ gdh1Δ), SCIGS24 (+ERG20", GDH2"), SCIGS25 (+ upc2-1", tHMG1") were cultivated at dilution rate D = 0.05 h-1. Error bars represent the
standard deviation from three independent cultivations.
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FPP between the two products remained unchanged when
the dilution rate was increased.
Surprisingly, strains SCIGS31, SCIGS24 and SCIGS25
were unable to sustain growth at D = 0.1 h-1 and cul-
tures were washed out (see section below).
Strain physiology in batch and chemostat cultivation
In order to evaluate if the modifications applied to in-
crease sesquiterpene production affected yeast physi-
ology a detailed characterization of the recombinant
strains was carried out. Control strain SCIGS28 dis-
played a fully respiratory metabolism (RQ = 1.0) under
both dilution rates. The principal physiological para-
meters (e.g. Ysx, rs, rCO2 and rO2) were comparable with
the wild type strain CEN.PK113-7D [37,38]. Strains
SCIGS29 and SCIGS30 exhibited major alterations in
their physiology. An increase in the residual glucose
concentration of 6.4 fold at D = 0.05 h-1 and 2.5 fold at
D = 0.1 h-1 was observed for both strains. As direct con-
sequence of the increase in the residual glucose concen-
tration aerobic fermentation set in, resulting in ethanolformation accompanied with acetate accumulation. A
marked reduction in the biomass yield from 0.5 to 0.29-
0.28 (D = 0.05 h-1) and 0.28-0.25 g biomass (g glucose)-1
(D = 0.1 h-1) was measured for the two strains (Table 1).
However, only a small fraction corresponding to 4%
(Cmmol products (Cmmol glucose)-1) of the glucose
consumed was fermented to ethanol and acetate. Add-
itionally, a clear increase in the glucose (rs) and oxygen
consumption rate (rO2) and carbon dioxide production
rate (rCO2) was observed (Table 1). This physiological
response was observed at both D = 0.05 and 0.1 h-1.
Despite several attempts, it was not possible to achieve a
steady-state when strains SCIGS31, SCIGS24 and
SCIGS25 were grown at D = 0.1 h-1. Instead, a progres-
sive decrease of the biomass concentration over time
was observed consistent with wash-out kinetics. The fol-
lowing characterization for these strains was therefore
conducted only at D = 0.05 h-1.
When deletion of GDH1 was introduced (strain
SCIGS31) a considerable fraction of the glucose,
31 mmol l-1, was recovered corresponding to a con-
sumption of only 33% of the total sugar provided.
Table 1 Physiological parameters measured during double-phase chemostat cultures of strains SCIGS28, SCIGS29,
SCIGS30, SCIGS31, SCIGS24 and SCIGS25
Strain D Yxs rs rCO2 rO2 retoh racet RQ Cs Cbalance Totsant
(h-1) (g g-1) (mmol g biomass-1 h-1) (rCO2/rO2) (mM) (%) (mg 24 h
-1 l-1)
SCIGS28 0.051 ±0.002 0.50 ±0.01 0.57 ±0.01 1.12 ±0.08 1.12 ±0.06 0 0 1.00 ±0.02 0.18 ±0.02 100.3 ±2.1 11.8 ±0.3
0.10 ±0.01 0.50 ±0.01 1.11 ±0.03 2.67 ±0.15 2.49 ±0.07 0 0 1.07 ±0.05 0.16 ±0.01 101.9 ±1.1 5.2 ±0.2
SCIGS29 0.050 ±0.003 0.29 ±0.01 0.97 ± 0.04 3.17 ±0.04 2.95 ±0.15 0.082 ±0.001 0.024 ±0.001 1.07 ±0.07 1.16 ±0.04 96.9 ±3.2 37.6 ±0.2
0.10 ±0.01 0.28 ±0.01 1.95 ±0.05 6.40 ±0.18 5.51 ±0.20 0.128 ±0.004 0.039 ±0.008 1.16 ±0.22 0.39 ±0.01 95.0 ±0.9 20.4 ±0.1
SCIGS30 0.051 ±0.001 0.28 ±0.02 1.09 ±0.05 3.60 ±0.09 3.41 ±0.22 0.099 ±0.015 0.024 ±0.003 1.05 ±0.09 1.15 ±0.04 94.7 ±0.4 39.4 ±0.4
0.10 ±0.02 0.25 ±0.01 2.26 ±0.09 7.70 ±0.19 6.37 ±0.29 0.161 ±0.007 0.032 ±0.005 1.21 ±0.14 0.40 ±0.01 93.5 ±1.2 20.1 ±0.1
SCIGS31 0.051 ±0.001 0.33 ±0.01 0.86 ±0.01 2.31 ±0.08 1.42 ±0.23 0.501 ±0.077 0.047 ±0.007 1.62 ±0.11 30.67 ±0.78 105.4 ±4.9 6.1 ±0.1
SCIGS24 0.051 ±0.001 0.24 ±0.01 1.16 ± 0.03 3.85 ±0.05 3.21 ±0.07 0.185 ±0.003 0.020 ±0.008 1.20 ±0.02 2.53 ±0.09 93.7 ±5.3 26.9 ±0.2
SCIGS25 0.048 ±0.003 0.21 ±0.01 1.26 ±0.02 4.41 ±0.04 3.82 ±0.04 0.195 ±0.005 0.027 ±0.007 1.16 ±0.03 2.91 ±0.14 93.8 ±2.9 24.9 ±0.3
μmax, specific growth rate (h
-1); D, dilution rate (h-1); Ysx, biomass yield (g biomass (g substrate)-1); specific consumption rates of glucose(rs), and oxygen (rO2)
(mmol (g biomass)-1 h-1); specific production rates of carbon dioxide (rCO2), ethanol (retoh),and acetate (racet) (mmol (g biomass)
-1 h-1). RQ, respiratory quotient
rCO2/rO2; Cs, residual glucose concentration (mM); Cbalance, carbon recovery (%); Totsant total amount of α-santalene produced (mg 24 h
-1 l-1). Values represent the mean ± S.D. of
three independent cultivations.
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this strain, the rate of alcoholic fermentation increased
to 0.51 mmol (g biomass)-1 h-1 and the metabolism
shifted more predominantly to a respiro-fermentative
state (RQ = 1.62), where 21% of the carbon source was
metabolized to the fermentation products ethanol and
acetate. These pronounced metabolic changes were
probably related to a limitation in ammonium consump-
tion as a consequence of Gdh1 inactivation.
Overexpression of GDH2 is known to partially com-
plement the ammonium assimilation defect in a gdh1Δ
strain [30] and resulted in a clear reduction of the etha-
nol and acetate production rate in strains SCIGS24 and
SCIGS25 compared to strain SCIGS31. It is worth
noticing that in strain SCIGS24, a large decrease in
the biomass yield occurred and the specific glucose
and O2 consumption rates and the CO2 production
rate increased respectively to a value of 1.16, 3.21 and
3.85 mmol (g biomass)-1 h-1. The previously described
overflow metabolism phenomenon towards fermentation
products was also observed in strains SCIGS24 and
SCIGS25 and led to a fraction of carbon fermented to
ethanol and acetate close to 6% for both strains. All engi-
neered strains except the control strain exhibited overflow
metabolism under the tested conditions. The fraction of
glucose converted into fermentation products ranged be-
tween 0.04 and 0.21 Cmmol products (Cmmol glucose)-1.
If strain SCIGS31 (which exhibited a behavior different
from all other strains probably related to the major role
played by the ammonium limitation) is excluded from this
consideration, it is interesting to notice that the ratios of
the different fermentation products measured vary sub-
stantially between the strains. A significantly higher etha-
nol: acetate ratio was observed for strains SCIGS24 and
SCIGS25 compared to SCIGS29 and SCIGS30 indicatinga redistribution of flux around the pyruvate dehydrogen-
ase (PDH) bypass at the acetaldehyde level. The increased
ethanol: acetate ratio was reflected in an increase in the
formation of sesquiterpene products, which are derived
directly from the cytosolic acetyl-CoA produced through
the pyruvate decarboxylase route. On the other hand, the
engineered strains showed a clear decrease in biomass
yield compared to the control strain suggesting a carbon
flux redirection towards other products. The fraction of
carbon lost in the drop of biomass yield could not be
accounted for in the residual unconsumed glucose or in
the fermentation products. Instead, carbon dioxide was
the main carbon product. Surprisingly, the increase in
ethanol and acetate productivity was not related to any
decrease in the respiration rate. The oxygen uptake
rate was increased in all engineered strains compared
to the control strain and reached the highest value of
4.41 mmol (g biomass)-1 h-1 in strain SCIGS25 suggesting
a strong reprogramming of cell metabolism in these
strains.
Discussion
In this study, we provide an example of several rounds of
metabolic engineering aimed at increasing the production
of the commercially relevant sesquiterpene compound
α-santalene. The strain improvement strategy was com-
bined with development of a cost effective fermentation
process based on a two-phase continuous cultivation
mode.
Double-phase chemostat as a tool to study metabolically
engineered strains
Continuous cultivation modes have been employed in
industrial bioprocesses (e.g. insulin production) and offer
several advantages compared to batch conditions [36].
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tivities of selected genetically engineered strains under
well-controlled constant conditions and to explore the
effect of the growth rate independently of the other
parameters.
Being extensively used in bioprocesses to produce
aroma compounds, in situ product removal (ISPR) (for
review see [39]) was applied in this study to maximize
the product recovery. Through the combination of ISPR
with chemostat cultivations we obtained a production
system that offers the advantage of continuous recovery
of the product in the fermented effluent from the
selected organic phase which can subsequently be
recycled, regenerated and reused in the same process for
a prolonged time of cultivation (for review see [40]) The
developed set-up is a suitable approach to develop an
upscale industrial process.
Influence of the genetic modifications on strain
productivity
Here we examined the impact of different metabolic en-
gineering strategies and their combinations on α-
santalene productivity and yield. The control strain was
minimally engineered to produce α-santalene function-
ally expressing a codon optimized santalene synthase
(SanSyn) from Clausena lansium and a truncated ver-
sion of 3-hydroxyl-3-methyl-glutaryl-coenzyme A reduc-
tase (HMGR). SanSyn belongs to the class I group of
sesquiterpene cyclase. These enzymes catalyze a complex
intramolecular cyclization of FPP with very different
product specificity and the reaction mechanism often
involves several partial reactions [41]. SanSyn has a high
specificity for α-santalene as its main product with only
minor amounts of trans-α-bergamotene formed [12].
Many studies have reported examples of heterologous
production of isoprenoids simply expressing the plant
synthase in the desired microbial host. However, the
yields obtained are often extremely low [15,19,20,42-45].
Similar to our previous study we decided to construct a
reference α-santalene producing strain (SCIGS 29) com-
bining the synthase expression with the expression of
the deregulated form of Hmg1 (tHmg1) [12]. The use of
tHMG1 represents an excellent example of bypassing
one of the regulatory mechanisms controlling the MVA
pathway flux and has been successfully applied in a
number of microbial isoprenoid production processes
[14,19-21,43]. The yield obtained in this control strain
was comparable with our previously reported values
obtained during a fed-batch process [12] and demon-
strates the feasibility and robustness in applying our
novel double-phase continuous cultivation. In order to
improve the production of the target compound it is ne-
cessary to overcome the regulatory mechanisms that
have evolved to prevent flux imbalances. In this work,we modulated some of the well-recognized key points
that tightly regulate the carbon flux to sesquiterpenes in
S. cerevisiae. A slight reduction in yield and unchanged
productivity observed in the control strain at a higher
dilution rate suggests a limitation of the plant synthase
in efficiently draining the FPP precursor from the MVA
pathway, consistent with the previous hypothesis that at
low FPP concentration SanSyn competes with the other
cellular FPP consuming reactions [12]. A general strat-
egy extensively applied in sesquiterpene bioprocess de-
velopment [14,15,20,35] consists in down-regulating
SQS to increase the intracellular FPP pool. Replacement
of the native PERG9 promoter with the glucose-sensing
PHXT1 promoter was recently successfully employed to
divert the carbon flux to sesquiterpene products instead
of sterols [12]. Applying the same ERG9 modification in
this study together with deletion of LPP1 greatly
increased the sesquiterpene productivity and yield under
chemostat conditions compared to the control strain.
The obtained productivity level appears to increase with
the dilution rate employed pointing to a direct relation
between the specific growth rate and the overall flux
through the MVA pathway and indicating that the effi-
ciency of the ERG9 modification in the enhanced FPP
availability was supported at different specific growth
rates. A similar growth dependent relation has been
reported for the cellular content of ergosterol [46],
which is also derived from FPP.
In the lpp1Δ and lpp1Δ/dpp1Δ mutants known to
exhibit lower FPP phosphatase activity [16,47], the ex-
cess of FPP was redistributed between α-santalene and
FOH in a consistent ratio when different dilution rates
were applied. These results suggest the hypothesis that
once a threshold level of intracellular flux toward FPP is
reached the thermodynamically favorable endogenous
dephosphorylation starts and competes with the catalytic
capacity of santalene synthase leading to FOH accumu-
lation. On the other hand, the unchanged α-santalene
yield coupled with higher productivity achieved at higher
dilution rates suggests that the santalene synthase was
not fully saturated at low dilution rates and there was
excess activity to cope with high FPP flux. This points
out that the FOH formation is not only a direct conse-
quence of limited santalene synthase activity but that
other cellular mechanisms are likely to be involved. Re-
duction but not complete inhibition of FOH formation
in the lpp1Δ dpp1Δ double deletion strain compared to
the single lpp1Δ deletion strain was consistent with our
previous report [12], and confirmed that the DPP1
encoded lipid phosphate phosphatase has a role in
FPP dephosphorylation and together with Lpp1 is
involved in the conversion of FPP into FOH. However,
these are clearly not the only mechanisms responsible
for this conversion as we still observed some FOH
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certain whether this is the result of the activity of
additional phosphatases or caused by non-enzymatic
hydrolysis.
Stoichiometry of the pathway reaction for α-santalene
formation from glucose reveals a net consumption of 0.4
mol of NADPH and net production of 1.2 mol of NADH
per Cmol of α-santalene formed. This fact renders the
sequiterpene production pathway a target for cofactor
engineering to improve its productivity. Improving the
NADPH availability by modifying the ammonium as-
similation pathway has proven to be an effective strategy
to increase sesquiterpene production [14]. Interestingly,
when the previously employed deletion of GDH1 to ma-
nipulate the cell redox metabolism was introduced a
reduction in α-santalene productivity without FOH
accumulation was obtained. This modification also
strongly affected the strain physiology (see below).
Therefore, it is likely that the limitation in ammonium
assimilation imposed by the GDH1 deletion reduces the
flux through the MVA pathway below the level necessary
to trigger FOH formation and conversion of FPP into
α-santalene was sufficient to avoid intracellular FPP
accumulation.
Combining the simultaneous overexpression of the
NAD-dependent glutamate dehydrogenase and prenyl
transferase encoded, respectively, by GDH2 and ERG20
positively affected sesquiterpene production. Overex-
pression of GDH2 is known to restore the ammonium
assimilation and consequently alter the NADH:NADPH
equilibrium favoring the NADPH availability at the ex-
pense of NADH produced [14, 30].
The consensus binding motif for the sterol biosyn-
thesis activating transcription factor Upc2 has been
found in most of the promoters of the ergosterol path-
way genes [35]. Moreover, it was shown that some genes
of the MVA pathway including ERG8, ERG12, ERG13,
ERG20 and HMG1 contain sequences similar to the con-
sensus binding sequence [32,48]. Expression of upc2-1
together with an additional copy of tHMG1 contributed
to increase the carbon flux through the MVA pathway
and had a beneficial effect on the total sesquiterpene
production. The fraction of FOH produced was almost
double in this strain and largely contributed to the
observed increase of total sesquiterpenes indicating that
when the flux toward sesquiterpene is altered through
the introduction of genetic modifications the FPP branch
point displayed an unexpected flexibility in product
distribution.
The optimal solution was obtained through combining
all the modifications resulting in the highest sesquiter-
pene yield (strains SCIGS24 and SCIGS25). Compared
to our previous study [12] the engineering strategy
employed here led to a 1.8-fold increase in α-santalenefinal yield (Cmmol α-santalene/Cmmol glucose). These
results highlight the importance of combining different
engineering strategies to achieve the goal of generating
an efficient platform strain for sesquiterpene production.
It is noteworthy that comparable sequiterpene product-
ivity was achieved in the strains not fully engineered
simply by increasing the operational dilution rate
(strains SCIGS29 and SCIGS30) whereas the fully engi-
neered strains were washed out when the same condi-
tions were imposed. Further studies are necessary to
elucidate the factors leading to the inability of these
mutants to sustain growth at higher dilution rates.
Influence of genetic modifications on strain physiology
In this study, the effect of controlling the diversion of
carbon flow from sterol synthesis towards sequiterpene
production by modifying the ERG9 promoter has been
investigated during aerobic chemostat glucose limited
cultivation conditions. The lpp1Δ and lpp1Δ/dpp1Δ
mutants carrying the PHXT1-ERG9 construct clearly
showed an increase in the residual glucose concentration
slightly above the critical concentration that triggers aer-
obic fermentation, which was reported to lie between 0.5
and 0.8 mM [49,50] and results in a typical Crabtree
response. It is possible that regulating the Erg9 activity
using the PHXT1 glucose sensitive promoter under strictly
glucose limited conditions resulted in its almost
complete down-regulation and in an increased biosyn-
thetic demand of the essential compound ergosterol.
Ergosterol is the main sterol present in the plasma mem-
branes where it has several essential functions [51].
Yeast is dependent on oxygen for sterol and fatty acid
formation. Under strictly anaerobic conditions this com-
pound has to be provided in the media. Reducing its
provision results in a decrease of biomass formation and
an increase in ethanol formation [52]. Activity of PHXT1
has been shown to be induced at an extracellular glucose
concentration of 5.6 mM [53] suggesting that the
observed increase in the residual glucose concentration
in the cultures was necessary to restore a minimal PHXT1
activity in order to maintain the ergosterol level neces-
sary to sustain cell growth. The response to the limita-
tion in the essential compound ergosterol could be the
reason leading to the observed decrease in biomass yield
and increase of the fermentative metabolism. A similar
phenomenon in fact was observed in auxotrophic yeast
strains in uracil-limited chemostat culture [54]. The
observed overflow metabolism toward ethanol and acet-
ate formation increases the carbon flux through the
PDH bypass possibly resulting in an increase in the
cytosolic acetyl-CoA availability that was subsequently
more efficiently channeled towards the MVA pathway in
the engineered strains enhancing the final sesquiterpene
production.
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needs to be discussed separately. Deletion of GDH1 is
known to impair the ammonium assimilation resulting
in a lower specific biomass formation rate on different
carbon sources (glucose/galactose) and under different
growth conditions (batch/chemostat and aerobic/anaer-
obic) [29,30], which was confirmed in this study. When
deletion of GDH1 was introduced, ethanol formation as
well as glucose accumulation occurred, resulting in a
situation similar to cultivation limited in essential nutri-
ents [54]. Most likely, the combination of the limitation
in ammonium assimilation as result of the GDH1 dele-
tion together with the possible ergosterol limitation due
to the ERG9 down regulation produced the observed
respiro-fermentative metabolism.
Conclusions
Microbial production of sesquiterpenes is an active
research area; advances in pathway engineering and fer-
mentation technologies have a significant impact in
accomplishing the aim to develop an economically viable
biobased industrial process. In this study, engineering
different pathways simultaneously resulted in a robust S.
cerevisiae production host capable of efficiently produ-
cing α-santalene. The engineered strains were evaluated
in an optimized double-phase continuous fermentation
method leading to a high yield of α-santalene and result-
ing in a robust production process that could possibly
be used for commercial applications. Levels of products
observed open up to the possibility to explore new en-
gineering option for increasing the sesquiterpene prod-
uctivity. The presented systematic metabolic engineering
approach represents a gateway toward the creation of
yeast platform that can be applied to the production of
an array of sesquiterpene products.Table 2 Plasmids used in this study
Plasmid name Plasmid description
pSP-GM2 URA3-based expression plasmid carryi
pICK01 PTEF1-SanSyn, PPGK1-tHMG1
pISP15 PTEF1-SanSynopt, PPGK1-tHMG1
pIGS01 PTEF1-ERG20
pIGS02 PTEF1-ERG20, AD1
PIGS03 PTEF1-ERG20, PPGK1-GDH2, AD1
pIGS04 PTEF1-ERG20, PPGK1-GDH2, AD1, AD2
pIGS05 PTEF1-ERG20, PPGK1-GDH2, AD1, AD2, Kl
pIGS06 PTEF1-ERG20 PPGK1-GDH2, AD1, 5´KlURA
pIGS07 PTEF1-tHMG1
pIGS08 PTEF1-tHMG1, PPGK1-upc2-1
pIGS09 PTEF1-tHMG1, PPGK1-upc2-1, AD3
pIGS10 PTEF1-tHMG1, PPGK1-upc2-1, AD3, 3´KlURMethods
Plasmid construction
An overview of the plasmids constructed in this study is
reported in Table 2, the detailed maps of the plasmids
are contained in Additional file 1. The gene coding for
α-santalene synthase (SanSynopt) was codon optimized
for expression in S. cerevisiae and synthesized by DNA
2.0 (Menlo Park, CA, USA) (Additional file 2), cut with
NotI/PacI and ligated into NotI/PacI restricted vector
pICK01 containing tHMG1 [12] resulting in plasmid
pISP15 (Figure 1).
To simultaneously integrate multiple genes into the
yeast genome a series of plasmids containing the genes,
constitutive strong promoters, terminators, marker gene
sequences and the required region for genomic integra-
tion were constructed. All endogenous S. cerevisiae
genes were PCR amplified using genomic DNA of strain
CEN.PK113-5D as template. Primers used for amplifica-
tion are provided in Additional file 3. All PCRs were
performed using high fidelity Phusion™ DNA polymerase
(Finnzymes, Vantaa, Finland). The ERG20 gene [GenBank:
NM_001181600] was amplified using primer pair 1/2,
subsequently digested with BamHI/NheI and ligated into
the vector pSP-GM2 [55] restricted with the respective
enzymes downstream of the TEF1 promoter resulting in
plasmid pIGS01. A 711 bp upstream flanking region
(AD1) selected for genomic integration was amplified
using primer pair 3/4, cut with MreI/Kpn2I and ligated
into vector pIGS01 restricted with the respective
enzymes resulting in plasmid pIGS02. Plasmid pIGS03
was obtained by cloning gene GDH2 [GenBank:
NM_001180275] amplified with primer pair 5/6 into
pIGS02 downstream of the PGK1 promoter using
PacI/NotI restriction sites. A downstream flanking re-
gion of 653 bp (AD2) was amplified with primers 7/8,Reference
ng a bidirectional PTEF1-PPGK1 promoter [55]
[12]
this study
this study
this study
this study
this study
URA3 this study
3 this study
this study
this study
this study
A3 this study
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resulting plasmid was named pIGS04. To complete the
plasmid for integration the Kluyveromyces lactis (Kl)
URA3 gene [GenBank: Y00454] was amplified with pri-
mers 9 and 10 using plasmid pWJ1042 [56] as tem-
plate, cut with FseI and ligated into pIGS04 after
restriction with the respective enzyme. The resulting
plasmid was designated pIGS05, digested with MreI/
AscI and the resulting fragment used for integration
into the yeast genome as described below. The 5´ re-
gion of the Kl URA3 gene was amplified with primers
11 and 12, cut with AvrII/AscI and cloned into pIGS03
restricted with the respective enzymes resulting in
plasmid pIGS06. Amplification of the catalytic domain
of the HMG-CoA reductase gene (tHMG1) [GenBank:
NM_001182434] was performed using primer pair 13/
14, the resulting fragment cleaved with NheI/BamHI
and cloned downstream of the TEF1 promoter into
NheI/BamHI restricted pSP-GM2 resulting in pIGS07.
A mutant allele upc2-1 of the UPC2 gene [GenBank:
NC_001180521] was created by use of primer pair 15/
16. To introduce the pleiotropic mutation G888D, the
corresponding codon GGT was mutated to GAT gener-
ating the amino acid substitution. Subsequently, the
PCR amplified upc2-1 was cloned downstream of the
PGK1 promoter into pIGS07 using NotI/PacI resulting
in plasmid pIGS08. An 829 bp downstream flanking
region (AD3) selected for genomic integration was
amplified using primer pair 17/18 cut with MreI/Kpn2I
and ligated into vector pIGS08 restricted with the re-
spective enzymes resulting in plasmid pIGS09. The 3´
region of Kl URA3 (overlapping with the 5´region
described above) was amplified with primers 19 and
20, cut with AvrII/AscI and cloned into pIGS09
restricted with the respective enzymes resulting in
plasmid pIGS10. All plasmids were verified by sequen-
cing (Sigma-Aldrich, St. Luis, MO). Subsequently, plas-
mids pIGS06 and pIGS10 were restricted with MreI/
AscI, the cassettes isolated from the vector backbone
and used for yeast transformation (see below).
Yeast strain construction
All S. cerevisiae strains constructed in this work have a
CEN.PK background with auxotrophy for uracil [57] and
are listed in Table 3.
Strain SCIGS03 carrying a GDH1 [GenBank: NC_001183795]
deletion was created from strain SCICK16 using a bi-
partite gene-targeting technique [55]. Upstream and
downstream region of GDH1 were amplified by PCR
from CEN. PK113-5D genomic DNA using primer
pairs 23/24 and 25/26. The loxP-kanMX-loxP cassette
was amplified from plasmid pUG6 [58] as two over-
lapping fragments using primer pairs 29/30 (5´ part)
and 31/32 (3´ part). By fusion PCR, the upstreamregion of GDH1 was combined with the 5´ part of
the kanMX cassette and the 3´ part of the kanMX
cassette with the downstream region of GDH1 and
the resulting fragments used to transform SCICK16.
Transformation was performed using the standard
lithium acetate procedure [59] and transformants
were selected using YPD plates containing 200 mg/l
G418 (Formedium, Hunstanton, UK). Correct integra-
tion of the kanMX cassette into the GDH1 locus was
tested by PCR using primers 27/28. The kanMX
marker was subsequently excised by transient trans-
formation with plasmid pSH47 containing the Cre re-
combinase encoding gene [58] leading to formation of
strain SCIGS03. Strain SCIGS06 carrying a genomic
integration of genes ERG20 and GDH2 under control
of the TEF1 and PGK1 promoter, respectively, was
obtained by transforming strain SCIGS03 with the
MreI/AscI fragment isolated from plasmid pIGS05.
Correct integration into the YORWΔ22 locus on
chromosome XV [60] was verified by PCR using pri-
mer pairs 33/1 and 5/34. Strain SCIGS12 carrying a
genomic integration of genes ERG20, GDH2, tHMG1
and upc2-1, was constructed by co-transforming
strain SCIGS03 with the MreI/AscI fragments isolated
from plasmids pIGS06 and pIGS10. Correct integra-
tion into the YORWΔ22 locus was verified by PCR
using primer pairs 33/1, 5/35, 19/15, 35/15, 16/36
and 13/34.
Kl URA3 was replaced in strains SCIGS06 and
SCIGS12 with the kanMX marker. The loxP-kanMX-
loxP cassette was independently amplified from plasmid
pUG6 using primer pair 37/38 for integration in strain
SCIGS06 and 39/40 for integration in SCIGS12 contain-
ing 71–74 bp primer tails complementary to the target
integration sites. Both strains were transformed with the
respective PCR-amplified fragment. Transformants were
selected on YPD plates containing 200 mg/l G418. Kl
URA3 replacement was initially tested by replica plating on
synthetic complete (SC) medium without uracil and YPD/
G418 medium. The kanMX marker was subsequently
removed [58] leading to strains SCIGS22 and SCIGS23.
Strains SCIGS28, SCIGS29, SCIGS30, SCIGS31, SCIGS24
and SCIGS25 were obtained transforming, respectively,
strains CEN.PK113-5D, SCICK01, SCICK16, SCIGS03,
SCIGS22 and SCIGS23 with the high copy number
plasmid pISP15 (Table 3) containing the URA3 gene
and the genes SanSynopt and tHMG1 under control of
the strong constitutive promoters TEF1 and PGK1, re-
spectively (Table 2).
Strain maintenance
Long term storage of yeast suspensions containing
25% (vol/vol) sterile glycerol was performed in cryo-
vials at −80°C [61]. Working stocks were maintained
Table 3 List of S. cerevisiae strains used in this study
Strain Genotype Plasmid Reference
CEN.PK113-5D MATa MAL2-8c SUC2 ura3-52 none P. Kötter, University
of Frankfurt, Germany
SCIGS28 MATa MAL2-8c SUC2 ura3-52 pISP15 this study
SCICK01 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP PERG9Δ::loxP-PHXT1 none [12]
SCIGS29 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP PERG9Δ::loxP-PHXT1 pISP15 this study
SCICK16 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP dpp1Δ::loxP PERG9Δ::loxP-PHXT1 none [12]
SCIGS30 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP dpp1Δ::loxP PERG9Δ::loxP-PHXT1 pISP15 this study
SCIGS03 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP dpp1Δ::loxP PERG9Δ::loxP-PHXT1 gdh1Δ::loxP none this study
SCIGS31 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP dpp1Δ::loxP PERG9Δ::loxP-PHXT1 gdh1Δ::loxP pISP15 this study
SCIGS06 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP
dpp1Δ::loxP PERG9Δ::loxP-PHXT1 gdh1Δ::loxP PTEF1-ERG20 PPGK1-GDH2 KlURA3
none this study
SCIGS22 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP
dpp1Δ::loxP PERG9Δ::loxP-PHXT1 gdh1Δ::loxP PTEF1-ERG20 PPGK1-GDH2
none this study
SCIGS24 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP
dpp1Δ::loxP PERG9Δ::loxP-PHXT1 gdh1Δ::loxP PTEF1-ERG20 PPGK1-GDH2
pISP15 this study
SCIGS23 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP dpp1Δ::loxP PERG9Δ::loxP-PHXT1 gdh1Δ::loxP
PTEF1-ERG20 PPGK1-GDH2 PTEF1-tHMG1 PPGK1-upc2-1
none this study
SCIGS12 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP
dpp1Δ::loxP PERG9Δ::loxP-PHXT1 gdh1Δ::loxP PTEF1-ERG20 PPGK1-GDH2
PTEF1-tHMG1 PPGK1-upc2-1 KlURA3
none this study
SCIGS25 MATa MAL2-8c SUC2 ura3-52 lpp1Δ::loxP
dpp1Δ::loxP PERG9Δ::loxP-PHXT1 gdh1Δ::loxP PTEF1-ERG20 PPGK1-GDH2
PTEF1-tHMG1 PPGK1-upc2-1
pISP15 this study
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casein peptone, 20 g/l glucose and 20 g/l agar. Plasmid
carrying strains were maintained on synthetic dextrose
medium agar plates lacking uracil containing 6.9 g/l yeast
nitrogen base without amino acids (Formedium), 0.77 g/l
complete supplement mixture without uracil (Forme-
dium) 20 g/l dextrose and 20 g/l agar.
Media and growth conditions
A mineral salts medium was used for batch cultivations
as previously described [62] and had the following com-
position (per liter): (NH4)2SO4, 5 g; KH2PO4, 3 g;
MgSO4•7H2O, 0.50 g; Antifoam 289 (A204, Sigma–
Aldrich), 0.05 ml; trace metals, 1 ml and vitamins, 1 ml.
The trace metal solution consisted of the following (per
liter): EDTA (sodium salt), 15.0 g; ZnSO4•7H2O, 0.45 g;
MnCl2•2H2O, 1 g; CoCl2•6H2O, 0.3 g; CuSO4•5H2O,
0.3 g; Na2MoO4•2H2O, 0.4 g; CaCl2•2H2O, 0.45 g;
FeSO4•7H2O, 0.3 g; H3BO3, 0.1 g and KI, 0.1 g. The
pH of the trace metal solution was adjusted to 4.0
with 2 M NaOH prior to heat sterilization. The vitamin
solution contained (per liter): biotin, 0.05 g; p-amino ben-
zoic acid, 0.2 g; nicotinic acid, 1 g; Ca-pantothenate, 1 g;
pyridoxine-HCl, 1 g; thiamine-HCl, 1 g and myo-inositol,
25 g. The pH of the vitamin solution was adjusted to 6.5
with 2 M NaOH. The vitamin solution was filter sterilized
and stored at 4°C. This medium was supplemented with 20g/l glucose. The feed composition used for continuous cul-
tivation had the same composition as described above, but
the glucose concentration was 10 g/l. The medium used
for shake flask cultivation has the same composition as
described above, but the (NH4)2SO4 concentration was
increased to 7.5 g/l, and the KH2PO4 to 14.4 g/l; the
glucose concentration was 20 g/l; the pH was adjusted
to 6.5 prior autoclaving.
Inoculum preparation and pre-culture
A single colony from an SC-ura agar plate was selected
to inoculate a 500 ml shake flask containing 100 ml min-
eral salts medium. The seed culture was grown at 30°C
in an orbital shaker at 100 rpm to late-exponential phase
and used to inoculate the fermenter to a final dry weight
of 1 mg/l. All cultivations were performed in triplicate.
Chemostat operation
Aerobic, carbon limited chemostat cultivations were per-
formed in 1.0 l stirrer pro vessels (DasGip, Jülich, Germany)
with a working volume of 0.3 l. The temperature was moni-
tored using a platinum RTD temperature sensor and kept
at 30°C using a BioBlock integrated heating and cooling
thermo well. Agitation was maintained at 600 rpm using an
overhead drive stirrer with one Rushton impeller. The air
flow rate was kept at 1 vvm by a mass flow controller
(DasGip). The pH was maintained constant at 5.0 by
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grated in a DasGip monitor and control system used to
control all fermentation parameters, temperature, agitation,
pH, and gas flow. Dissolved oxygen was monitored using
an autoclavable polarographic oxygen electrode (Mettler
Toledo, Columbus, OH) and maintained above 30% satur-
ation via regulating stirrer speed and gas flow rate. Exhaust
gas was cooled, dried and the gas composition was analyzed
for real time continuous determination of oxygen and car-
bon dioxide concentration by a DasGip fed batch proW gas
analysis system with off gas analyzer GA4 based on zirco-
nium dioxide and two-beam infrared sensor. The integrated
mass flow sensor allowed on-line monitoring and calcula-
tion of oxygen transfer rate (OTR), carbon dioxide transfer
rate (CTR) and respiratory quotient (RQ). The chemostat
bioreactor was initiated as batch culture with 10 g/l glucose.
Only after the residual ethanol produced was completely
consumed the feed was started and the fermentation run in
a continuous mode. Fermenters were operated at dilution
rate 0.05 or 0.1 h-1. A two-phase product partition chemo-
stat was performed by co-feeding medium containing
10 g/l glucose and the organic phase (Figure 2). To obtain a
dilution rate of 0.1 h-1, the inlet medium was fed at 27 ml/h
and the organic phase at 3 ml/h. To obtain a dilution rate
of 0.05 h-1, medium was fed at 13.5 ml/h and the organic
phase at 1.5 ml/h resulting in a constant inlet feed ratio of
medium: organic phase of 9:1 (vol/vol). Dodecane (Sigma-
Aldrich, St. Luis, MO) was used as organic phase and filter
sterilized prior addition. The culture working volume of
0.3 l (0.27 l of medium + 0.03 l of dodecane) was kept con-
stant by automatic withdrawal of broth based on an electric
level sensor measurement. The set-up allowed maintaining
the correct medium/organic phase ratio inside the fermen-
ted throughout the fermentation time. The correct ratio of
9:1 vol/vol between the two phases was constantly moni-
tored and differed by less than 2% in samples taken directly
from the culture and from the effluent line. Steady state
was reached after at least 5 residence times, defined by con-
stant values of CTR, OTR and biomass concentration (less
than 5% deviation).
Cell mass determination
Cell growth during fermentation was monitored off-line
by measuring optical density and dry cell weight and on-
line with an optical density transmitter OD4 sensor
(DasGip) integrated in the fermenter system. The optical
density at 600 nm was determined using a Genesis20
spectrophotometer (Thermo Scientific, Madison, WI,
USA). The cell dry weight was measured by filtering
known culture volumes through pre-dried and pre-
weighed 0.45-μm-pore size nitrocellulose filters (Sartorious
Stedim Biotech GmbH, Göttingen, Germany). The filters
with the biomass were washed with water, dried for 15
min in a microwave oven at 150 W, and weighed again.The correlation factor between off-line and on-line para-
meters was determined.
Metabolite analysis
Samples for analysis of extracellular metabolite concen-
trations were withdrawn from two-phase steady state
chemostat cultures and centrifuged for 5 min at 5000 g.
The organic layer was discarded and the cultivation
broth was filtered through 0.45-μm-pore size nylon fil-
ters (VWR international, Radnor, PA, USA) and stored
at −20°C until further analysis. Glucose, glycerol acetate,
succinate, and pyruvate were quantified by HPLC
(UltiMateW 3000 Nano, Dionex, Bannockburn, IL, USA)
with an Aminex HXP-87 H ion-exchange column (Bio-Rad,
Hercules, CA) maintained at 65°C and using 5 mM
H2SO4 as mobile phase at a flow rate of 0.6 ml min
-1.
Glucose, glycerol, and ethanol were measured with a
refractive index detector (Shodex RI-101, Showa Denko,
Tokyo, Japan), and acetate, succinate, and pyruvate
were measured with a UV-visible light absorbance de-
tector (UltiMate 3000 Variable Wavelength Detector,
Dionex).
Analysis of sesquiterpenes
Sequiterpene production was determined as described pre-
viously [12] with minor modifications. Culture samples
were centrifuged 15 min at 5000 g and the organic layer
was diluted with an equal volume of dodecane containing a
defined amount of α-humulene as internal standard. Sam-
ples were diluted in heptane and analyzed by gas chroma-
tography–mass spectrometry (Thermo Scientific) equipped
with an SLB-5 ms capillary column (30 m, 0.25 mm i.d.,
0.25 μm film thickness; Supelco, Bellefonte, PA, USA). Full
mass spectra were generated by scanning the m/z range
within 40–500 for metabolite identification. Sesquiterpene
identification was carried out comparing mass spectra and
retention time with authentic standards, concentrations
were calculated using a correction factor determined for
the internal standard α-humulene relative to α-santalene
and E,E-farnesol.
Additional files
Additional file 1: Maps of plasmids constructed in this study. (A)
pISP15, (B) pIGS01, (C) pIGS02, (D) pIGS03, (E) pIGS04, (F) pIGS05, (G)
pIGS06, (H) pIGS07, (I) pIGS08, (L) pIGS09, (M) pIGS10.
Additional file 2: Codon optimized santalene synthase nucleotide
sequence.
Additional file 3: Primers used in this study. Restriction sites are
indicated in bold face, overlapping nucleotides are underlined, and the
modified codon is indicated in italic.
Abbreviations
CTR: Carbon dioxide transfer rate; DMAPP: Dimethylallyl diphosphate;
ER: Endoplasmic reticulum; FOH: Farnesol; FPP: Farnesyl diphosphate;
FPPS: Farnesyl diphosphate synthase; GPP: Geranyl diphosphate; HMGR:
Scalcinati et al. Microbial Cell Factories 2012, 11:117 Page 15 of 16
http://www.microbialcellfactories.com/content/11/1/1173-hydroxy-3-methyl-glutaryl-CoA reductase; IPP: Isopentenyl diphosphate;
ISPR: In situ product removal; MVA: Mevalonate; OTR: Oxygen transfer rate;
PDH: Pyruvate dehydrogenase; RQ: Respiratory quotient; SanSyn: Santalene
synthase; SQS: Squalene synthase.
Competing interests
GS, SP, VS and JN declare they have no competing interests. MS and LD are
employees of Firmenich SA.
Authors' contributions
JN and GS participated in the design of the study. JN and VS supervised the
project. GS performed the experimental work. SP assisted in the molecular
biology experiments. MD and LD assisted in the GC/MS analysis of
sesquiterpens. GS analyzed the data and wrote the manuscript. All the
authors discussed the results, edited and approved the final manuscript.
Acknowledgements
This work has been financed by Firmenich SA, the Knut and Alice
Wallenberg Foundation and Chalmers Foundation.
Author details
1Department of Chemical and Biological Engineering, Chalmers University of
Technology, SE-412 96, Göteborg, Sweden. 2Firmenich SA, Corporate R&D
Division, CH-1211, Geneva 8, Switzerland.
Received: 2 March 2012 Accepted: 18 August 2012
Published: 31 August 2012
References
1. Leonard E, Ajikumar PK, Thayer K, Xiao W, Mo JD, Tidor B, Stephanopoulos
G, Prather KLJ: Combining metabolic and protein engineering of
terpenoid biosynthetic pathway for overproduction and selectivity
control. PNAS 2010, 107:13654–13659.
2. Daviet L, Schalk M: Biotechnology in plant essential oil production:
progress and perspective in metabolic engineering of the terpene
pathway. Flavour Fragr J 2010, 25:123–127.
3. Kirby J, Keasling JD: Biosynthesis of plant isoprenoids: perspectives for
microbial engineering. Annual Rev Plant Biol 2009, 60:335–355.
4. Chang MC, Keasling JD: Production of isoprenoid pharmaceuticals by
engineered microbes. Nat Chem Biol 2006, 2:674–681.
5. Khalil AS, Collins JJ: Synthetic biology: applications come of age. Nat Rev
Gen 2010, 11:367–379.
6. Fowler ZL, Koffas M: Microbial biosynthesis of fine chemicals: an
emerging technology. In The metabolic pathway engineering handbook:
tools and applications. 1st edition. Edited by Smolke CD. Boca Raton: CRC
Press; 2010.
7. Fortman JL, Chhabra S, Mukhopadhyay A, Chou H, Lee TS, Steen E, Keasling
JD: Biofuel alternatives to ethanol: pumping the microbial well. Cell 2008,
26:375–381.
8. Maury J, Asadollahi MA, Møller K, Clark A, Nielsen J: Microbial isoprenoid
production: an example of green chemistry through metabolic
engineering. Adv Biochem Eng Biotechnol 2005, 100:19–51.
9. Ohto C, Muramatsu M, Obata S, Sakuradani E, Shimizu S: Production of
geranylgeraniol on overexpression of a prenyl diphosphate synthase
fusion gene in Saccharomyces cerevisiae. Appl Microbiol Biotechnol 2010,
87:1327–1334.
10. Schalk M: Method for producing alpha-santalene. 2011, US Pat
2011/008836 A1.
11. Keasling JD: Synthetic biology for synthetic chemistry. ACS Chem Biol
2008, 3:64–67.
12. Scalcinati G, Knuf C, Partow S, Chen Y, Maury J, Schalk M, Daviet L, Nielsen J,
Siewers V: Dynamic control of gene expression in Saccharomyces
cerevisiae engineered for the production of plant sesquitepene α-
santalene in a fed-batch mode. Metab Eng, doi:10.1016/j.
ymben.2012.01.007.
13. Takahashi S, Yeo Y, Greenhagen BT, McMullin T, Song L, Maurina-Brunker J,
Rosson R, Noel JP, Chappell J: Metabolic engineering of sesquiterpene
metabolism in yeast. Biotechnol Bioeng 2007, 97:170–181.
14. Asadollahi MA, Maury J, Schalk M, Clark A, Nielsen J: Enhancement of
farnesyl diphosphate pool as direct precursor of sesquiterpenes throughmetabolic engineering of the mevalonate pathway in Saccharomyces
cerevisiae. Biotechnol Bioeng 2010, 106:86–96.
15. Asadollahi MA, Maury J, Møller K, Nielsen KF, Schalk M, Clark A, Nielsen J:
Production of plant sesquiterpenes in Saccharomyces cerevisiae: effect of
ERG9 repression on sesquiterpene biosynthesis. Biotechnol Bioeng 2008,
99:666–677.
16. Faulkner A, Chen X, Rush J, Horazdovsky B, Waechter CJ, Carman GM,
Sternweis PC: The LPP1 and DPP1 gene products account for most of the
isoprenoid phosphate phosphatase activities in Saccharomyces cerevisiae.
J Biol Chem 1999, 274:14831–14837.
17. Hampton RY, Rine J: Regulated degradation of HMG-CoA reductase, an
integral membrane protein of the endoplasmic reticulum, in yeast. J Cell
Biol 1994, 125:299–312.
18. Polakowski T, Stahl U, Lang C: Overexpression of a cytosolic
hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in
yeast. Appl Microbiol Biotechnol 1998, 49:66–71.
19. Jackson BE, Hart-Wells EA, Matsuda SP: Metabolic engineering to produce
sesquiterpenes in yeast. Org Lett 2003, 5:1629–1632.
20. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA,
Eachus RA, Ham TS, Kirby J, Chang MCY, Withers ST, Shiba Y, Sarpong R,
Keasling JD: Production of the anitmalarial drug precursor artemisinic
acid in engineered yeast. Nature 2006, 440:940–943.
21. Kirby J, Romanini DW, Paradise EM, Keasling JD: Engineering triterpene
production in Saccharomyces cerevisiae - beta-amyrin synthase from
Artemisia annua. FEBS J 2008, 275:1852–1859.
22. Anderson MS, Yarger JG, Burck CL, Poulter CD: Farnesyl diphosphate
synthetase. Molecular cloning, sequence, and expression of an essential
gene from Saccharomyces cerevisiae. J Biol Chem 1989, 264:19176–19184.
23. Wang K, Ohnuma S: Chain length determination mechanism of isoprenyl
diphosphate synthases and implications for molecular evolution. TIBS
1999, 24:445–451.
24. Daum G, Lees ND, Bard M, Dickson R: Biochemistry, cell biology and
molecular biology of lipids of Saccharomyces cerevisiae. Yeast 1998,
14:1471–1510.
25. Chambon C, Ladeveze V, Oulmouden A, Servouse M, Karst F: Isolation and
properties of yeast mutants affected in farnesyl diphosphate synthetase.
Curr Genet 1990, 18:41–46.
26. Grabinska K, Palamarczyk G: Dolichol biosynthesis in the yeast
Saccharomyces cerevisiae: an insight into the regulatory role of farnesyl
diphosphate synthase. FEMS Yeast Res 2002, 2:259–265.
27. Szkopinska A, Swiezewska E, Karst F: The regulation of activity of main
mevalonic acid pathway enzymes: farnesyl diphosphate synthase,
3-hydroxy-3-metylglutaryl-CoA reductase, and squalene synthase in yeast
Saccharomyces cerevisiae. Biochem Biophys Res Commun 2000, 267:473–477.
28. Hou J, Scalcinati G, Oldiges M, Vemuri GN: Metabolic impact of increased
NADH availability in Saccharomyces cerevisiae. Appl Environ Microbiol 2010,
76:851–859.
29. Nissen TL, Kielland-Brandt MC, Nielsen J, Villadsen J: Optimization of
ethanol production in Saccharomyces cerevisiae by metabolic
engineering of the ammonium assimilation. Metab Eng 2000, 2:69–77.
30. dos Santos M, Thygesen G, Kötter P, Olsson L, Nielsen J: Aerobic physiology
of redox-engineered Saccharomyces cerevisiae strains modified in the
ammonium assimilation for increased NADPH availability. FEMS Yeast Res
2003, 4:59–68.
31. Asadollahi M, Maury J, Patil KR, Schalk M, Clark A, Nielsen J: Enhancing
sesquiterpene production in Saccharomyces cerevisiae through in silico
driven metabolic engineering. Metab Eng 2009, 11:328–334.
32. Vik Å, Rine J: Upc2p and Ecm22p, dual regulators of sterol biosynthesis in
Saccharomyces cerevisiae. Mol Cell Biol 2001, 21:6395–6405.
33. Lewis TL, Keesler AG, Fenner GP, Parks W: Pleiotropic mutations in
Saccharomyces cerevisiae affecting sterol uptake and metabolism. Yeast
1988, 4:93–106.
34. Davies BSJ, Wang HS, Rine J: Dual activators of the sterol biosynthetic
pathway of Saccharomyces cerevisiae: similar activation/regulatory
domains but different response mechanisms. Mol Cell Biol 2005,
25:7375–7385.
35. Paradise EM, Kirby J, Chan R, Keasling JD: Redirection of flux through the
FPP branch-point in Saccharomyces cerevisiae by down-regulating
squalene synthase. Biotechnol Bioeng 2008, 100:371–378.
36. Nielsen J, Villadsen J, Liden G: Bioreaction Engineering Principles. New York:
Kluwer Plenum; 2003.
Scalcinati et al. Microbial Cell Factories 2012, 11:117 Page 16 of 16
http://www.microbialcellfactories.com/content/11/1/11737. Raghevendran V, Patil KR, Olsson L, Nielsen J: Hap4 is not essential for
activation of respiration at low specific growth rates in Saccharomyces
cerevisiae. J Biol Chem 2006, 281:12308–12314.
38. Diderich JA, Schepper M, Van Hoek P, Luttik MA, Van Dijken JP, Pronk JT,
Klaassen P, Boelens HF, Teixeira-de-Mattos J, Van Dam K, Kruckeberg AL:
Glucose uptake kinetics and transcription of HXT genes in chemostat
cultures of Saccharomyces cerevisiae. J Biol Chem 1999, 274:15350–15359.
39. Stark D, von Stockar U: In situ product removal (ISPR) in whole cell
biotechnology during last twenty years. Adv Biochem Eng Biotechnol 2003,
80:150–175.
40. Van Sonsbeek HM, Beeftink HH, Tramper J: Two-phase bioreactors. Enzyme
Microb Technol 1993, 15:722–729.
41. Christianson DW: Unearthing the roots of the terpenome. Curr Opin Chem
Biol 2008, 12:141–150.
42. Wang C, Yoon HS, Jang JH, Chung RY, Kim YJ, Choi SE, Kim WS: Metabolic
engineering of Escherichia coli for α-farnesene production. Metab Eng
2011, 13:648–655.
43. Farhi M, Marhevka E, Masci T, Marcos E, Eyal Y, Ovadis M, Abeliovich H,
Vainstein A: Harnessing yeast subcellular compartments for the
production of plant terpenoids. Metab Eng 2011, 13:474–481.
44. Madsen KM, Udatha GD, Semba S, Otero JM, Koetter P, Nielsen J, Ebizuka Y,
Kushiro T, Panagiotou G: Linking genotype and phenotype of
Saccharomyces cerevisiae strains reveals metabolic engineering targets
and leads to triterpene hyper-producers. PLoS One 2011, 6:e14763.
45. DeJong JM, Liu Y, Bollon AP, Long RM, Jennewein S, Williams D, Croteau RB:
Genetic engineering of taxol biosynthetic genes in Saccharomyces
cerevisiae. Biotechnol Bioeng 2005, 93:212–224.
46. Arnezeder C, Hample WA: Influence of growth rate on the accumulation
of ergosterol in yeast-cells. Biotechnol Lett 1990, 12:277–282.
47. Carman GM, Wu WI: Lipid phosphate phosphatases from Saccharomyces
cerevisiae. Methods Enzymol 2007, 434:305–315.
48. Chiang DY, Moses AM, Kellis M, Lander ES, Eisen MB: Phylogenetically and
spatially conserved word pairs associated with gene-expression changes
in yeast. Genome Biol 2003, 4:R43.
49. Woehrer W, Roehr M: Regulatory aspects of Bakers’ yeast metabolism in
aerobic fed-batch cultures. Biotechnol Bioeng 1981, 23:567–581.
50. Verduyn C, Zomerdijk TPL, van Dijken JP, Scheffers A: Continuous
measurement of ethanol production by aerobic yeast suspensions with
an enzyme electrode. Appl Microbiol Biotechnol 1984, 19:181–185.
51. van der Rest ME, Kamminga AH, Nakano A, Anraku Y, Poolman B, Konings
WN: The plasma membrane of Saccharomyces cerevisiae: structure,
function, and biogenesis. Microbiol Rev 1995, 59:304–322.
52. Verduyn C, Postma E, Scheffers WA, van Dijken JP: Physiology of
Saccharomyces cerevisiae in anaerobic glucose-limited chemostat
cultures. J Gen Microbiol 1990, 136:395–403.
53. Özcan S, Johnston M: Three different regulatory mechanisms enable
yeast hexose transporter (HXT) genes to be induced by different levels
of glucose. Mol Cell Biol 1995, 15:1564–1572.
54. Basso TO, Dario MG, Tonso A, Stambuk BU, Gombert AK: Insufficient uracil
supply in fully aerobic chemostat cultures of Saccharomyces cerevisiae
leads to respiro-fermentative metabolism and double nutrient-limitation.
Biotechnol Lett 2010, 32:973–997.
55. Rodriguez-Limas W, Tyo KEJ, Nielsen J, Ramirez T, Palomares LA: Molecular
and process design for rotavirus-like particle production in
Saccharomyces cerevisiae. Microb Cell Fact 2011, 10:33.
56. Reid RJD, Sunjevaric I, Kedacche M, Rothstein R: Efficient PCR-based gene
disruption in Saccharomyces strains using intragenic primers. Yeast 2002,
19:319–328.
57. Van Dijken JP, Bauer J, Brambilla L, Duboc P, Francois JM, Gancedo C,
Giuseppin ML, Heijnen JJ, Hoare M, Lange HC, Madden EA, Niederberger P,
Nielsen J, Parrou JL, Petit T, Porro D, Reuss MN, van Riel N, Rizzi M,
Steensma HY, Verrips CT, Vindelov J, Pronk JT: An interlaboratory
comparison of physiological and genetic properties of four
Saccharomyces cerevisiae strains. Enzyme Microb Technol 2000, 26:706–714.
58. Güldener U, Heck S, Fiedler T, Beinhauer J, Hegemann JH: A new efficient
gene disruption cassette for repeated use in budding yeast. Nucleic Acids
Res 1996, 24:2519–2524.
59. Gietz RD, Woods RA: Transformation of yeast by lithium acetate/single
stranded carrier DNA/polyethylene glycol method. Methods Enzymol 2002,
350:87–96.60. Flagfeldt DB, Siewers V, Huang L, Nielsen J: Characterization of
chromosomal integration sites for heterologous gene expression in
Saccharomyces cerevisiae. Yeast 2009, 26:545–551.
61. Sherman F: Fink GR, Hicks JB: Methods in yeast genetics – Laboratory Manual.
New York: Cold Spring Harbor; 1986.
62. Verduyn V, Postma E, Scheffers WA, Van Dijken JP: Effect of benzoic acid
on metabolic fluxes in yeasts: a continuous-culture study on the
regulation of respiration and alcoholic fermentation. Yeast 1992,
8:501–517.
doi:10.1186/1475-2859-11-117
Cite this article as: Scalcinati et al.: Combined metabolic engineering of
precursor and co-factor supply to increase α-santalene production by
Saccharomyces cerevisiae. Microbial Cell Factories 2012 11:117.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
